Photo Release -- Centuria Natural Foods Selects Cannabis Sativa, Inc. to Market Proprietary Precision-Dosed, Water-Soluble CBD Hemp Oil Nutraceuticals Under the Brand Name "hi."
March 03, 2015 at 01:45 AM EST
MESQUITE, Nev., March 3, 2015 (GLOBE NEWSWIRE) -- Cannabis Sativa, Inc. (OTC QB: CBDS) (referred to collectively with its subsidiaries as "CBDS") today announced its wholly owned subsidiary, Hi Brands International, Inc., has entered into an agreement with Centuria Natural Foods, Inc. to market their proprietary CBD Rich Hemp Oil products.
A photo accompanying this release is available at http://www.globenewswire.com/newsroom/prs/?pkgid=31123
"We're excited to team up with CBDS. We see their brand advantage and they see what sets us apart, specifically our quality control measures and the superiority of our finished products," said Centuria Natural Foods CEO, Michael Brubeck. "In addition, we utilize a proprietary process called 'lipid-modification.' Cannabidiol in its naturally occurring state, using oil as a carrier, has extremely poor oral bioavailability, at an average of only 6%. We've overcome that.
"We've modified the lipid structure of the carrier oil so that it becomes water soluble," Brubeck explained. "That's an enormous leap. Water is one of the most readily-absorbed molecules in the digestive system – as opposed to oils, which have remarkably poor permeability. Water solubility is a key component for improving bioavailability. We've not only cracked the bioavailability code – we've rewritten it. Our process 'supercharges' CBD's efficacy by substantially increasing the amount of active ingredient delivered to the body. The implications for health and wellness speak for themselves. Moreover, the value to the consumer is exponential; if a company can boost the bioavailability of cannabidiol in hemp oil from its current average of 6% to a bioavailability of 60%, then a consumer is getting ten times more value for their money, in addition to a supplement that's 10 times as effective."
"Another thing that distinguishes this product is precision dosing," said former New Mexico Governor Gary Johnson, President and CEO of Cannabis Sativa, Inc. and Hi Brands International, Inc. "For the first time, consumers can get the advantages of this wondrous, naturally-occurring compound legally and with complete confidence that their dosage is exact, that they are receiving the maximum benefit possible from every capsule, and that the quality is consistent."
The reputation for hemp-based CBD products has suffered bumps and bruises in recent years. Centuria Natural Foods CEO, Michael Brubeck, believes that's about to change.
"Quality control issues have plagued hemp companies for years – from heavy metal toxicity and microbial growth, to THC and THC-A exceeding federal limits," Brubeck said. "We've gone overboard to counter that. Our hemp products pass rigid quality control measures, including High Pressure Liquid Chromatography and Gas Chromatography to test every step of the manufacturing process. Air, water, and soil are tested in the field to ensure the European farms we use have pristine and optimal growing conditions. We test midseason and post-harvest to assure plant cannabinoid and terpene profiles remain within the standard deviation for agricultural products. Once in our (cGMP, HACCP, USDA Naturally Organic Program, Kosher, Halal and ISO 9001 Certified) processing facility, all hemp products undergo a proprietary, multistage filtering process to eliminate all adulterants, such as trace amounts of THC and THC-A, as well as any other unwanted contaminants. Finished products are sealed in nitrogen to prevent oxidation while in cold storage, providing our customers and consumers the highest quality hemp ingredients on the market."
"Consumers won't have to pay excessive prices for this superior product," said CBDS Chairman, Steven Kubby. "It's our desire to bring the benefits of CBD to the masses at a price point that will encourage daily consumption. Our customers may well be ingesting the most tried, tested, proven and overly-scrutinized CBD supplement in the nutraceutical industry, which is what our company is all about. We're excited to enter the CBD arena with the best product and, arguably, the strongest branding in the marketplace."
Governor Johnson also believes the future of CBD oil supplements is a bright one.
"Go online," Johnson urges. "Read all about it. This gift of nature is lighting up the news, chat rooms, bulletin boards and the medical community, with reports of dramatic clinical implications for conditions ranging from Alzheimer's Disease and seizures to certain cancers and MS. We make no claims – and won't – because we don't have to. The information age is doing that for us."
Cannabis Sativa, Inc. plans to market their CBD capsules under the name, "hi CBD." Each capsule contains 7.5 mg of water-soluble CBD and is sold in bottles of sixty capsules, which constitutes the recommended monthly usage of 2 capsules per day. The Company plans to be delivering product, both online and in retail locations, by the spring of 2015.
About Cannabis Sativa, Inc.
Cannabis Sativa Inc. is a fully reporting company with an experienced management team. President and CEO, Gary Johnson, is a former Governor, Libertarian Party Presidential Candidate, and seasoned businessman. The Company has acquired the research and development company KUSH along with its founder, activist and innovator, Steven Kubby, who occupies the position as Chairman. Board members include former Senator Mike Gravel, Alaska; California Superior Court Judge, Jim Gray (Ret.) and Stephen Downing, former LAPD Deputy Chief of Police and Executive Producer of several series including, MacGyver, Robocop, and Fx – The Series.
CBDS is in the business of branding, licensing, innovating and marketing superior plant-derived topical creams, transdermals, balms, sublinguals, lubricants and edibles for medical and recreational marijuana consumers – as well as legal nutraceuticals and branded merchandise for consumers at large. The Company plans to license the "hi" brand to distributors and producers of quality products and to other ancillary participants in the retail cannabis industry. Cannabis Sativa, Inc. is traded on the bulletin board under the symbol of CBDS.
About Centuria Natural Foods, Inc.
Centuria Natural Foods, Inc. launched in 2014 after recruiting cannabinoid and agriculture expert Michael Brubeck as CEO. Brubeck has a 10-year history of leading companies throughout the world in both hemp and cannabis industries, as well as pharmaceutical research organizations. The combination of experience in research and development of pharmaceutical products allowed Centuria to apply the same proprietary technologies and methods of quality control to manufacturing hemp foods. The result of using superior agricultural products alongside superior processing practices, make Centuria Hemp Products the new standard in the nutritional cannabinoid space.
Derived from hemp seed, stalk and fiber, Centuria's CBD-rich hemp oil products retain all the synergistic cannabinoids and terpenoids necessary for highest potency and efficacy. Centuria CBD hemp oil is derived from high-grade, non-psychoactive, EU- Certified industrial hemp plants as a botanical extract, not as a synthetic-compound or isolate, as is the case with other CBD products on the market. The products offer optimal therapeutic doses of the beneficial cannabidiol molecule found in the cannabis plant, in a form that is legal for purchase and consumption in all fifty states by consumers of any age.
This press release contains "forward-looking statements." Although the forward-looking statements in this release reflect the good faith judgment of management, forward-looking statements are inherently subject to known and unknown risks and uncertainties that may cause actual results to be materially different from those discussed in these forward-looking statements. Readers are urged to carefully review and consider the various disclosures made by us in our reports filed with the Securities and Exchange Commission, including the risk factors that attempt to advise interested parties of the risks that may affect our business, financial condition, results of operation and cash flows. If one or more of these risks or uncertainties materialize, or if the underlying assumptions prove incorrect, our actual results may vary materially from those expected or projected. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release.
More information on the products, as well as the science of CBD, can be found here:
Stock symbol: CBDS
The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.
CONTACT: Investor Relations Cannabis Sativa, Inc. Mesquite, NV (702) 345-4074